Spontaneous crystalline‐to‐amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 2: Amorphization capacity and mechanisms of interaction-Reference-Cited by-同舟云学术

Spontaneous crystalline‐to‐amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 2: Amorphization capacity and mechanisms of interaction

Published:2011-11 Issue:11 Volume:100 Page:4674-4686
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Qian Ken K.,Suib Steven L.,Bogner Robin H.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference38 articles.

1. Amorphous pharmaceutical solids: Preparation, characterization, and stabilization;Yu;Adv Drug Deliv Rev,2001

2. Solid state amorphization of pharmaceuticals;Willart;Mol Pharm,2008

3. Interaction of medicinals and porous powder. I. Anomalous thermal behavior of porous glass mixtures;Nakai;Chem Pharm Bull,1984

4. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. I. Effect of vapor pressure of the medicinals on changes in crystalline properties;Konno;Chem Pharm Bull,1986

5. Amorphization of indomethacin by co‐grinding with Neusilin US2: Amorphization kinetics, physical stability and mechanism;Bahl;Pharm Res,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amorphization of Ethenzamide and Ethenzamide Cocrystals—A Case Study of Single and Binary Systems Forming Low-Melting Eutectic Phases Loaded on/in Silica Gel;Pharmaceutics;2023-04-13

2. The nanocopper interface induces the formation of a new ultrastable glass phase;Journal of Non-Crystalline Solids;2022-10

3. Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels;Drug Delivery;2022-07-15

4. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies;Molecular Pharmaceutics;2020-05-11

5. Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material properties;Drug Development and Industrial Pharmacy;2019-01-15